Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.

Zarek J, Brydon A, Spitzer K, Laskin C, Ito S

Open source

DOI
10.1016/j.ero.2025.03.001
Published
2025 Apr
Container
EULAR rheumatology open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ero.2025.03.001,
  title = {Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.},
  author = {Zarek J and Brydon A and Spitzer K and Laskin C and Ito S},
  year = {2025},
  journal = {EULAR rheumatology open},
  doi = {10.1016/j.ero.2025.03.001},
  url = {https://doi.org/10.1016/j.ero.2025.03.001}
}

RIS

TY  - JOUR
TI  - Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.
AU  - Zarek J
AU  - Brydon A
AU  - Spitzer K
AU  - Laskin C
AU  - Ito S
PY  - 2025
JO  - EULAR rheumatology open
DO  - 10.1016/j.ero.2025.03.001
UR  - https://doi.org/10.1016/j.ero.2025.03.001
ER  - 

APA

J, Z., A, B., K, S., C, L., & S, I. (2025). Pregnancy-associated exposure reduction to medications used for antiphospholipid syndrome: a systematic review.. EULAR rheumatology open. https://doi.org/10.1016/j.ero.2025.03.001

Source records